Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Diabetes Injection Pens also called insulin pens are used by people with diabetes to inject insulin. The pens include an insulin cartridge, a dial to measure dosage.
Global Diabetes Injection Pens key players include Novo Nordisk, Eli Lilly, Sanofi, BD, etc. Global top four manufacturers hold a share nearly 65%.
Europe is the largest market, with a share over 40%, followed by Asia-Pacific, and North America, both have a share about 50 percent.
In terms of product, Disposable Insulin Pens is the largest segment, with a share over 70%. And in terms of application, the largest application is Retail Pharmacy, followed by Hospital and Clinic, Online Sales, etc.
The global Diabetes Injection Pens market was valued at US$ 4185 million in 2020 and is expected to reach US$ 6490.1 million by the end of 2027, growing at a CAGR of 6.4% during 2021-2027.
This report focuses on Diabetes Injection Pens volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Diabetes Injection Pens market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Diabetes Injection Pens Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Reusable Insulin Pens
Disposable Insulin Pens
Segment by Application
Hospital and Clinic
Retail Pharmacy
Online Sales
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Novo Nordisk
Eli Lilly
Sanofi
BD
Ypsomed Holding
Dongbao
Owen Mumford
Ganlee
Delfu
Global Diabetes Injection Pens key players include Novo Nordisk, Eli Lilly, Sanofi, BD, etc. Global top four manufacturers hold a share nearly 65%.
Europe is the largest market, with a share over 40%, followed by Asia-Pacific, and North America, both have a share about 50 percent.
In terms of product, Disposable Insulin Pens is the largest segment, with a share over 70%. And in terms of application, the largest application is Retail Pharmacy, followed by Hospital and Clinic, Online Sales, etc.
The global Diabetes Injection Pens market was valued at US$ 4185 million in 2020 and is expected to reach US$ 6490.1 million by the end of 2027, growing at a CAGR of 6.4% during 2021-2027.
This report focuses on Diabetes Injection Pens volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Diabetes Injection Pens market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Diabetes Injection Pens Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Reusable Insulin Pens
Disposable Insulin Pens
Segment by Application
Hospital and Clinic
Retail Pharmacy
Online Sales
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Novo Nordisk
Eli Lilly
Sanofi
BD
Ypsomed Holding
Dongbao
Owen Mumford
Ganlee
Delfu
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
